EUVIMEDSkopri EUVIMED
Crossref

Impact of Adeno‐Associated Virus Production on Capsid Heterogeneity and Product Quality

Alex Meola, Xiaotong Fu iD, Sarah Laughlin, Thomas Thiers, Luke Mustich, Eli Wiberg, Yongseok Kim, Qi Zhang, Eugenia Fandunyan, Richa Jaiswal, Matt Perez, Ben Rogers and 9 more

Biotechnology and Bioengineering · 2026

DOI: 10.1002/bit.70219 ↗

At a glance

Journal article in Biotechnology and Bioengineering, 2026. Written by Alex Meola and 20 co-authors. Institution: Oxford Biomedica (US) LLC, Bedford, Massachusetts, USA. Major MEDLINE topics: Dependovirus, Capsid, Capsid Proteins. 23 references. Funded by: Oxford Biomedica (US) LLC.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Adeno‐associated virus (AAV) capsids are inherently heterogeneous, arising from viral protein stoichiometric assembly, post‐translational modifications, genome packaging, and manufacturing process conditions. Understanding how AAV manufacturing processes affect capsid heterogeneity and corresponding drug product quality impact is essential for AAV‐based gene therapies. We investigated the effects of extended production duration and capsid localization at harvest on capsid heterogeneity. Analytical characterization revealed that prolonged production increased extracellular AAV concentrations but also elevated the proportion of empty capsids, overall hydrophobicity, and deamidation of viral protein (VP). These changes altered charge‐dependent separation during anion exchange chromatography (AEX). Capsids derived from intracellular fractions showed even higher levels of deamidation and empty particles compared to extracellular populations, further impacting AEX purification performance. Collectively, these findings demonstrate that both production time and capsid localization significantly influence AAV purification process performance and critical quality attributes. Process control strategies to minimize capsid heterogeneity are consequently critical to ensure a consistent quality profile in AAV manufacturing.

Subjects

MeSH terms (MEDLINE)

DependovirusCapsidCapsid ProteinsChromatography, Ion ExchangeHumansVirus Assembly

Author keywords

AAV capsid heterogeneityAAV product qualityanion exchange chromatographydeamidationempty and full separationproduction duration

Substances

Capsid Proteins

Authors and institutions

  • Oxford Biomedica (US) LLC, Bedford, Massachusetts, USA.

ORCID profiles: Xiaotong Fu

Funding

  • Oxford Biomedica (US) LLC

Cite

APA

Meola, A., Fu, X., Laughlin, S., Thiers, T., Mustich, L., Wiberg, E., Kim, Y., Zhang, Q., Fandunyan, E., Jaiswal, R., Perez, M., Rogers, B., DaSilva, E., Rouleau, D., Lushi, R., Horton, R., Brazell, B., Mercaldi, M., Yin, J., …, & Iwuchukwu, I. (2026). Impact of Adeno‐Associated Virus Production on Capsid Heterogeneity and Product Quality. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.70219

Vancouver

Meola A, Fu X, Laughlin S, Thiers T, Mustich L, Wiberg E, et al. Impact of Adeno‐Associated Virus Production on Capsid Heterogeneity and Product Quality. Biotechnology and Bioengineering. 2026. doi:10.1002/bit.70219

BibTeX
@article{Meola2026,
  author = {Meola, Alex and Fu, Xiaotong and Laughlin, Sarah and Thiers, Thomas and Mustich, Luke and Wiberg, Eli and Kim, Yongseok and Zhang, Qi and Fandunyan, Eugenia and Jaiswal, Richa and Perez, Matt and Rogers, Ben and DaSilva, Evan and Rouleau, David and Lushi, Rudenc and Horton, Rob and Brazell, Brian and Mercaldi, Michael and Yin, Jin and McGivney, James and Iwuchukwu, Ify},
  title = {Impact of Adeno‐Associated Virus Production on Capsid Heterogeneity and Product Quality},
  journal = {Biotechnology and Bioengineering},
  year = {2026},
  doi = {10.1002/bit.70219}
}
Start for free →